Nitric Oxide Synthase 2, Inducible (NOS2) (AA 772-787) antibody

Details for Product No. ABIN968055
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms NOS2A, INOS, iNOS, INO1, IPS, IPS 1, IPS-1, HEP-NOS, NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNos, NOS2, NOS2a
Epitope
AA 772-787
(38), (16), (15), (8), (7), (6), (6), (5), (4), (2), (2), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Reactivity
Mouse (Murine)
(149), (81), (51), (12), (12), (12)
Host
Mouse
(161), (21)
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
(4), (3), (3), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Application
Western Blotting (WB), Immunofluorescence (IF)
(124), (77), (57), (48), (40), (39), (16), (15), (12), (11), (10), (3), (1), (1), (1), (1)
Pubmed 4 references available
Quantity 50 μg
Options
Shipping to United States (Change)
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN968055
Contact our Customer Service for availability and price in your country.
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Mouse iNOS
Clone 2
Isotype IgG1
Characteristics 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
4. Please refer to us for technical protocols.
Purification Purified from tissue culture supernatant or ascites by affinity chromatography.
Alternative Name iNOS/NOS Type II
Background Nitric oxide synthase (NOS), a cell-type specific enzyme, catalyzes the synthesis of nitric oxide (NO). NO is a short-lived radical that transmits cellular signals involved in vasorelaxation, neurotransmission, and cytotoxicity. In macrophages and other cell types, NOS (iNOS or macNOS) activity increases following exposure to cytokines (IFN-gamma, TNF-alpha, and IL-1) and microbial products (lipopolysaccharide (LPS)). iNOS isactivated independently of Ca2+/calmodulin and its level of expression is tightly controlled by several transcription factors, including NFkappaB. Data indicates that TGF-ß affects translation of iNOS mRNA and decreases iNOS protein stability. Normally undetectable in brain tissue, iNOS mRNA has been observed in CNS tissues of animals under experimental pathologic conditions. iNOS and nNOS share 51% amino acid homology with the greatest degree of divergence in the calmodulin binding domain.
Synonyms: NOS Type II
Molecular Weight 130 kDa
Comment

Related Products: ABIN968550, ABIN967389

Restrictions For Research Use only
Format Liquid
Concentration 250 µg/ml
Buffer Aqueous buffered solution containing BSA, glycerol.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Supplier Images
anti-Nitric Oxide Synthase 2, Inducible (NOS2) (AA 772-787) antibody Western blot analysis of iNOS/NOS Type II on a cell lysate from mouse macrophages (RAW 264.7) stimulated with 10 ng/mL IFNgamma and 1 µg/mL LPS for 12 hours. Lane 1: 1:250, Lane 2: 1:500, Lane 3: 1:1000 dilution of the mouse anti- mouse iNOS/NOS Type II antibody.
Product cited in: Xie, Cho, Calaycay et al.: "Cloning and characterization of inducible nitric oxide synthase from mouse macrophages." in: Science (New York, N.Y.), Vol. 256, Issue 5054, pp. 225-8, 1992 (PubMed).

Nathan, Xie: "Regulation of biosynthesis of nitric oxide." in: The Journal of biological chemistry, Vol. 269, Issue 19, pp. 13725-8, 1994 (PubMed).

Koprowski, Zheng, Heber-Katz et al.: "In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 90, Issue 7, pp. 3024-7, 1993 (PubMed).

Vodovotz, Bogdan, Paik et al.: "Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta." in: The Journal of experimental medicine, Vol. 178, Issue 2, pp. 605-13, 1993 (PubMed).

Validation Images
Did you look for something else?
back to top